Estate Plan Targeting In 10 Steps thenonprofittimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thenonprofittimes.com Daily Mail and Mail on Sunday newspapers.
Rediscovering investment opportunities in real estate bworldonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bworldonline.com Daily Mail and Mail on Sunday newspapers.
Silence Therapeutics Announces Publication in Cardiovascular Research Highlighting the Emerging Potential of RNA Therapeutics in Preventing Lipoprotein(a)-Mediated Cardiovascular Disease - High Lipoprotein(a) is a genetically determined cardiovascular risk factor affecting around 20% of the world s population LONDON, Silence Therapeutics plc , AIM: SLN and Nasdaq: SLN ( Silence or the Company ), a leader in the discovery, development and delivery of novel short interfering ribonucleic acid (siRNA) therapeutics for the treatment of diseases with significant unmet medical need, today announced a new review publication on the prevention of cardiovascular disease linked to high lipoprotein(a) - Lp(a) - levels in the latest issue of Cardiovascular Research,
10 Indicators For Estate Plan Donor Targeting
December 23, 2020
Gender and childlessness have always been among the leading indicators for charitable gifts in estate planning. New research has identified a top 10 list of lifetime characteristics that are most important in predicting charitable transfers.
“The Emerging Potential of Longitudinal Empirical Research in Estate Planning: Examples from Charitable Bequests” is based on the Health and Retirement Study (HRS), which includes nationally representative data that has come out biannually since 1992. The HRS tracked more than 14,000 people since age 50 to connect lifetime giving and other characteristics and planning and seeing where estates actually have been transferred.